−19.5714USD
−17.565MUSD
19.701M
About TransCode Therapeutics, Inc.
Sector
Industry
CEO
Robert Michael Dudley
Website
Headquarters
Boston
Employees (FY)
19
Founded
2016
ISIN
US89357L2043
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
$RNAZ is gonna fall todayPupm&Dump trading strategy idea.
$RNAZ is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $7,85;
stop-loss — $8,47;
take-profit — $6,62.
Do not view th
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
